Data completeness
3/8 — Basic
LACTULOSE (lactulose) by Sanofi is osmotic activity [moa].
Drug data last refreshed 19h ago · AI intelligence enriched 2mo ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
Lactulose is an osmotic laxative available in oral and rectal solution formulations that works by drawing water into the colon to promote bowel movements. It is indicated for constipation and hepatic encephalopathy management. The drug functions through osmotic activity, increasing stool frequency and softening consistency.
Pre-Launch
As a pre-launch asset, this product represents a building phase with smaller team sizes and focus on launch readiness and market preparation activities.
Mechanism of Action
Osmotic Activity
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (13)
Effects of Lactulose on Gut Microbiota and Metabolism in Diabetic Constipated Patients
Started Jul 2023
60 enrolled
Diabetes MellitusConstipation - Functional
Prevention of Post-TIPS Hepatic Encephalopathy by Administration of Rifaximin and Lactulose
Started Jan 2020
238 enrolled
Hepatic EncephalopathyCirrhosis, LiverPortal Hypertension+2 more
Blood Glucose Response After Oral Intake of Lactulose in Mildly Constipated Patients With Diabetes Mellitus Type 2
Started Nov 2018
24 enrolled
Diabetes Mellitus, Type 2
Rifaximin Soluble Solid Dispersion (SSD) Tablets Plus Lactulose for the Treatment of Overt Hepatic Encephalopathy (OHE)
Started Sep 2018
71 enrolled
Overt Hepatic Encephalopathy
Safety and Efficacy of Rifaximin in Patients With Papulopustular Rosacea and Positive Lactulose Breath Test
Started Jun 2018
236 enrolled
Papulopustular Rosacea
Worked on LACTULOSE at Sanofi? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.